Integrative transcriptomic profiling links telomere dysfunction to cGAS–STING activation in heart failure signatures in mice and humans
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvag013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Moritz Brandt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center, Langenbeckstraße 1, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Heart Failure, Membrane Proteins, Nucleotidyltransferases, Gene Expression Profiling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, German Federal Ministry for Education and Research, German Research Foundation (DFG) Major Research Instrumentation Program.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Cardiomyocyte telomere shortening is evident during heart failure pathogenesis. Conversely, mice with engineered telomerase deficiency develop myocardial dysfunction accompanied by p53 activation and mitochondrial repression. We aimed to address fundamental gaps in knowledge: whether cardiac dysfunction in mice lacking telomerase components arises from myocardial-intrinsic effects or systemic consequences of telomere shortening, which broader transcriptional programs follow, and what implications these have for clinical heart failure. Methods and results We generated telomerase-deficient mice until generation 5 (mTRG5) and confirmed shortening telomeres along with increasing cardiac dysfunction by cardiovascular phenotyping and cardiomyocyte mitochondrial function assessment. Transcriptional and regulator analysis confirmed the telomere -p53 -mitochondria axis but extended beyond it, revealing additional involvement of neurohumoral activation, senescence, and inflammation, notably type I interferon signaling. To contextualize these findings, we compared this profile with hypertensive heart failure induced by neurohumoral dysregulation (angiotensin II infusion, nephrectomy, salt overload; ANS) and established a transcriptional hierarchy. In mTRG5 mice, regulators of telomere dysfunction and p53 activation ranked highest by significance and centrality, supporting telomere shortening as the primary upstream driver. Reciprocally, ANS mice showed higher-ranking neurohumoral regulators, indicating these govern secondary pathways. To pursue the strong type I interferon profile, we utilized myocardial profiles of mice lacking three-prime exonuclease 1, an established activator of the cGAS -STING pathway. Matching the profiles, we confirmed pronounced activation of cGAS -STING in mTRG5 mice –and slightly less in ANS mice –providing first evidence for cGAS -STING activation in telomere shortening and heart failure. Integration of the mTRG5 signature with curated transcriptomic datasets from murine and human dilated and ischemic cardiomyopathy revealed robust cross-species and cross-etiology overlap that increased with heart failure severity and decreased with functional recovery.
Conclusion
These findings establish telomere dysfunction as a pathogenic driver that engages innate immune signaling via the cGAS -STING pathway, with direct relevance to human heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center, Langenbeckstraße 1, 55131 Mainz, Germany.
- Center for Thrombosis and Hemostasis, University Medical Center, Langenbeckstraße 1, 55131 Mainz, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Rhine-Main.
- Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA 94305, USA.
- Stanford Cardiovascular Institute, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
- Department of Cardiology and Pneumology, Heart Center at the University Medical Center, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
ORCID-Profile: Moritz Brandt, Megan Mayerle, Uwe Raaz, Philipp Lurz, Philip Wenzel, Helen M Blau
Förderung
- NIA NIH HHS
- German Federal Ministry for Education and Research
- German Research Foundation (DFG) Major Research Instrumentation Program
- DFG
- Stiftung Mainzer Herz
- Boehringer Ingelheim Foundation
- American Heart Association
- National Institute of Health
Zitieren
APA
Brandt, M., Khraisat, S., Luo, Q., Mayerle, M., Raaz, U., Tsao, P., Münzel, T., Lurz, P., Wenzel, P., & Blau, H. M. (2026). Integrative transcriptomic profiling links telomere dysfunction to cGAS–STING activation in heart failure signatures in mice and humans. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag013
Vancouver
Brandt M, Khraisat S, Luo Q, Mayerle M, Raaz U, Tsao P, et al. Integrative transcriptomic profiling links telomere dysfunction to cGAS–STING activation in heart failure signatures in mice and humans. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag013
BibTeX
@article{Brandt2026,
author = {Brandt, Moritz and Khraisat, Sana'a and Luo, Qi and Mayerle, Megan and Raaz, Uwe and Tsao, Phil and Münzel, Thomas and Lurz, Philipp and Wenzel, Philip and Blau, Helen M},
title = {Integrative transcriptomic profiling links telomere dysfunction to cGAS–STING activation in heart failure signatures in mice and humans},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag013}
}
EUVIMED